Cette étude vise à étudier les changements de comportement et de santé mentale pendant la pandémie de COVID-19 dans la population française.
Consejo Superior de Investigaciones Científicas (CSIC), Spain
Study on the development of a prototype vaccine against SARS-CoV-2 that can be administered intranasally in a single dose.
Institut Català de la Salut, Spain
This study aims to demonstrate efficacy of Montelukast for patients with persistent COVID-19 to help them improve their quality of life.
Hospital Clínic Barcelona, Spain
CIBERES UCI COVID is a fundamental study that will improve care of critical patients infected by COVID-19.
National Research Center for Hematology et. al., Russia
A Russian study to determine the severity and lethality of COVID-19 infection in patients with hematologic diseases.
Catalunya Central Health region, Spain
Early administration of convalescent plasma in people over 50 years of age with mild to moderate COVID-19 disease may slow disease progression and decrease the severity of symptoms.
This study conducted by the UOC aims to find out the opinion of the Spanish population and professional healthcare personnel on the COVID-19 vaccines.
MOOD-COVID aims to study the impact of the pandemic on the mental health of pregnant women, young mothers and their children.
Institut Hospital del Mar d’Investigacions Mèdiques, Spain
This study aims to assess the mental health impact and needs associated with COVID-19 in Spain.
This study aims to determine the effects of vaccination against SARS-CoV-2 in people with long COVID.
Instituto de Salud Carlos III, Spain
Clinical trial designed to evaluate the safety and immunogenicity of a dose of Comirnaty vaccine (Pfizer) in people who have previously received a dose of Vaxcevria vaccine (AstraZeneca).